DARETODREAM PROJECT
LIVE

Serial Number

97423768

Owner

Blood Cancer United, Inc.

Attorney

Andrew D. Price

First Use Date

May 22, 2022

Filing Date

May 23, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DARETODREAM PROJECT Trademark

Serial Number: 97423768 • Registration: 7600110

DARETODREAM PROJECT is a trademark filed by Blood Cancer United, Inc. on May 23, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Blood Cancer United, Inc. (85 trademarks)

1201 15th Street N.W., Suite 410
Washington, DC 20005

Entity Type: 54

THE LEUKEMIA & LYMPHOMA SOCIETY, INC. (142 trademarks)

1311 MAMARONECK AVENUE
WHITE PLAINS, NY 10605

Entity Type: 99

Trademark Details

Filing Date

May 23, 2022

Registration Date

December 10, 2024

First Use Anywhere

May 22, 2022

First Use in Commerce

May 22, 2022

Published for Opposition

December 26, 2023

Goods & Services

Accepting and administering monetary charitable contributions in the field of cancer; providing financial sponsoring for clinical trials in the field of cancer

Providing patient education services services in the nature of classes, courses, and workshops in the field of cancer

Providing medical counseling and information about medical terms and clinical trials to patients, families, and healthcare providers in the field of cancer, including helping children, patients, caregivers, parents and physicians to identify appropriate clinical trials for children with cancer; providing information in the field of cancer treatment; providing nutritional consultations to patients, families, and caregivers in the field of cancer

Conducting clinical trials in the nature of medical research in the field of cancer; consulting services for others, namely, helping others design, plan, implement, and manage clinical trials in the field of cancer

Promoting the interests of cancer patients and medical professionals in the field of cancer by means of public advocacy; promoting public awareness of cancer by means of public advocacy

Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support in the field of cancer

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 1, 2025 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 20, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 20, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 23, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2024 AITU
USE AMENDMENT FILED
Aug 19, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 19, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 20, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2023 NONP
EXPARTE APPEAL TERMINATED
Nov 20, 2023 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 20, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 20, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 20, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 20, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 14, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Nov 14, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Nov 14, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Nov 14, 2023 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 14, 2023 GNFN
FINAL REFUSAL E-MAILED
Aug 14, 2023 GNFR
FINAL REFUSAL WRITTEN
Aug 14, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2023 CRFA
ASSIGNED TO LIE
Jul 10, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 8, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 8, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 8, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2022 NWOS
NEW APPLICATION ENTERED
May 26, 2022 NWAP